Avacta Group (LON:AVCT) Share Price Crosses Above 200 Day Moving Average – Time to Sell?

Avacta Group Plc (LON:AVCT)’s share price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 68.39 and traded as high as GBX 72. Avacta Group shares last traded at GBX 69, with a volume of 862,553 shares.

Avacta Group Stock Performance

The company has a debt-to-equity ratio of 602.46, a quick ratio of 4.96 and a current ratio of 0.89. The stock’s fifty day moving average price is GBX 72.59 and its 200-day moving average price is GBX 68.39. The company has a market capitalization of £323.30 million, a P/E ratio of -7.14 and a beta of 1.12.

Avacta Group (LON:AVCT) last posted its quarterly earnings results on Tuesday, May 19th. The biotechnology company reported GBX (9.27) EPS for the quarter. The business had revenue of GBX 11 million for the quarter. Avacta Group had a negative return on equity of 2,929.47% and a negative net margin of 33,961.06%. As a group, research analysts anticipate that Avacta Group Plc will post -9.9011833 EPS for the current fiscal year.

Avacta Group Company Profile

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).